Welcome to the Utah Chapter of the American College of Cardiology
|
Ed Miner, MD, FACC Utah, Chapter President ACC Governor, Utah |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!. For more information and to register, please visit:
ACC Rockies Chapter Meeting 2025
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- C-TRACT: Endovascular Therapy For Post-Thrombotic Syndrome Reduces Severity, Improves QOLEndovascular therapy added to standard care for post-thrombotic syndrome was associated with improved syndrome severity and quality of life (QOL) at six months compared with standard care alone in patients with moderate or severe post-thrombotic syndrome and iliac vein-obstruction...
- ACC.26 Sports and Exercise Cardiology: Key Takeaways From the 75th Annual Scientific SessionsThe Sports and Exercise Cardiology sessions at American College of Cardiology Annual Scientific Session 2026 (ACC.26) reinforced a central theme: exercise is both medicine and, in select contexts, a risk.
- And That's a Wrap! ACC.26: An ACPC Perspective From a First-Time AttendeeAttending the American College of Cardiology Annual Scientific Session 2026 (ACC.26) for the first time as a trainee in pediatrics was an eye-opening and astonishing experience.
- ACC Practice Made Perfect: How to Get Your Start in AdvocacyIn this episode of ACC’s Practice Made Perfect podcast, Drs. Brenton Bauer and Laura Onderko explore practical strategies for getting started in advocacy, with a particular focus on Fellows in Training and Early Career cardiologists.
- ACC CardiaCast: ATTR-CM Treatment: Recent UpdatesIn this episode, Drs. Ahmad Masri and Kevin Alexander review emerging clinical data in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at the Heart Failure Society of America Annual Scientific Meeting and the American Heart Association Scientific Sessions 2025, including key findings from the ATTRibute-CM and HELIOS-B trials.